Solid State Pharma Inc.

Conducting IND enabling studies, identifying the optimal salt and polymorph, hydrate studies, amorphous to crystalline conversion with a success rate exceeding 70%, DC lead CMC studies, and particle engineering are some of the value-generating activities that the Solid State Pharma team performs for clients. We ensure client success through proprietary workflows that integrate the fundamentals of crystallization and solid-state science with years of experience.